Skip to main content Deutsch

Klinische Forschung - Colorektale Chirurgie

Sorry, this content is only available in German!


Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer

NCT04488159 Collaboration with J Galon.
Status: Ethic Approved. Recruiting Financial Support
Autors: Längle, Bergmann


Neoadjuvant CHemoradiotherapy with sequential Ipilimumab and NivOlumab in RECtal cancer: a prospective randomized, open-label, multicenter, phase II clinical trial

EudraCT No 2019-003865-17,  NCT 04124601 
Financial Support: Bristol Myers Squibb
Status: Recruiting
Authors: Längle, Bergmann

Comparison of PET radio-imaging patterns with immunohictochmistry protein expression pattern in colorectal cancer liver metastases using CXCR4 as target structure.

Financial Support: LBI-Applied diagnostic
Status: recruiting
PI Bergmann

Crohn’s disease: Evalution of Intestinal Fibrosis by FAPI-PET-MR-Enterography: a prospective non-randomized open-label single-center pilot study.

Support: MUV
Status: recruting
PI Scharitzer, CoAutor: Bergmann

A multicenter, randomized, controlled, open label trial on the efficacy and safety of Asunercept for patients with severe COVID-19 disease

Support: Apogenix, Heidelberg
Status: recruiting
CoAutor: Bergmann


Programmed death-ligand 1 positron Emission Tomography imaging during Neoadjuvant (chemo)radiothErapy in esophageal and rectal Cancer: a prospective non-randomized open-label single-center pilot study

Support: MUV
Status: Ethical approval pos. Seeking compound.
Authors: Längle, Bergmann

Pretherapeutic evaluation of Colorectal Liver Metastasis by FAPI-PET-MRI: A prospective non-randomized open-label single-centre pilot study

Support: LBI and MUV
Status: Seeking Ethical Approval
Authors: Jedamzik, Bergmann